Stay on top of changes like the AMP cap removal.
Read moreKey dates and requirements from the recent CMS Medicare implementation memos.
Read moreThoughts on the first round of the Inflation Reduction Act drug price negotiations.
Read moreVA has begun preparations for the 2025 Public Law. Here is what you need to get started.
Read moreCMS rules published as part of the Physician Fee Schedule for 2025.
Read moreWhat the Authorized Generics are, and how they are treated in Government Pricing calculations and commercially.
Read moreObservations from the FTC report on the impact of PBMs on drug pricing.
Read moreThe Q4 2023 GP reporting cycle was the first quarter with the shortened IFF reporting & payment requirements in effect.
Read moreIRA defines gradually increasing rebate rates that will apply in various manufacturer scenarios.
Read moreThe IRA sunsets CGDP as of 1/1/2025. The deadline to enter the new Part D Program agreement for 2025 is March 1, 2024.
Read moreLet's review the key Medicare Part D manufacturer rebate program changes.
Read moreAfter receiving industry feedback, including ours, CMS has corrected the calculation of the coinsurance adjustment percentage for several products.
Read moreLisa and Scott will be at the Asembia specialty pharmacy summit.
Read moreDave received the Distribution Management Award for Industry Leadership from the HDA.
Read moreJennifer Katona, our Partner, Client Services is moderating a Medicaid Automation session at the Medicaid & GP Congress.
Read moreCMS released its initial guidance for the implementation of the Medicare Part B and Part D Prescription Drug Inflation Rebates.
Read moreEffectively telling Your GP story to various stakeholders is an art. Here are the key considerations to keep in mind.
Read moreVisit our booth at MDRP Chicago Oct 12-14, and come by Scott's session on Accuracy of Inputs into GP Calculations.
Read moreWe're delighted to welcome Lisa Arthurs as Vice President, Sales & New Business Development. Lisa has joined to drive the adoption of our services and technology across the pharma manufacturer industry.
Read moreWe received a SOC 1 Type 2 certification. The audit examined our managed service practices and security, and confirmed that we serve our clients reliably and safely.
Read moreWe are going to be at the Medicaid & GP Congress in Philadelphia, and Scott is speaking on there on May 24th. Our team looks forward to meeting you at the event!
Read moreMDRP 2021 is happening in person October 11-13. Scott Hoffman is speaking at a couple of sessions. Come by and say hello!
Read moreA playbook for when it's time for you to update accruals around all your government financial liabilities.
Read moreScott is moderating a Product Launch, Divestiture, and Acquisition Challenges workshop on June 8.
Read moreOne of the steps in launching or acquiring your first product is deciding on government contracting. Fortunately, once you know the requirements, this can be straightforward.
Read moreIn this post I focus on Best Price and the BP True-up. We look at a couple of factors to consider when establishing your BP methodology and the True-up process.
Read moreThe Senate recently passed H.R. 1319, the $1.9T stimulus package. Amongst many changes to Medicaid, the new legislature ends the AMP cap for Unit Rebate Amounts.
Read moreAn introduction to the three key components of gross to net modeling: market access channels, stacking, and the pricing strategy.
Read moreWe are happy to share that we just received a SOC 1 Type 1 certification. The SOC audit examined our managed service policies and procedures, and our platform security and reliability practices, to ensure that we serve our clients reliably and safely.
Read moreAt Woven Data, we use a concept of "True Payer Mix", which is instrumental at all stages of the product life cycle, from acquisition due diligence, commercialization, to ongoing brand management.
Read moreOur goal at Woven Data is to provide analytical tools and managed services to drive commercial success for pharmaceutical manufacturers. In this blog, we'll be covering our experiences in all of the areas that we touch: market access, government pricing, contracting, and M&A diligence and reporting. You will be seeing my name on many of these posts, so I figure this is as good a time as any to introduce myself.
Read more